We not only investigated the relationship of common gene mutations such as EGFR, ALK, ROS1 and NSCLC metastasis, but also extended the gene spectrum to rare gene mutations such as KRAS, HER2, BRAF, RET, MET, and PIK3CA. This evidence concerns the gene RET and non-small cell lung carcinoma.